Work

A prospective double-blind, randomised, phase 3 study of the efficacy of ketamine for oral and pharyngeal mucositis pain: KARM study (ketamine analgesia for refractory mucositis pain).

Year: 2025

Type: conference-abstract

Source: JCO Oncology Practice

DOI: 10.1200/op.2025.21.10_suppl.296

Authors: Khunthong Peechatanan, Peter Poon, Tim Powers, Jade Hudson, Shu Min Wong, Naomi Katz

Institutions: Phramongkutklao Hospital, Phramongkutklao College of Medicine, Monash Medical Centre, Monash Health, Monash University, The Alfred Hospital, Alfred Health

Language: English

Topic: Pain Management and Opioid Use

Subfield: Anesthesiology and Pain Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4414893274

Cites:

Cited by:

Related to: